Clinical Trial Update: Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors

View source ↗

Summary

An international observational study on neurotoxicity and cognition in long-term survivors of Primary Central Nervous System Lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Primary Central Nervous System Lymphoma (PCNSL) | Status: TERMINATED